$4.38
-0.12[-2.67%]
At close: Apr 19
$4.38
0[0.00%]
PreMarket: 6:00AM EDT
Aquestive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | PM | AQST | Q1 | $0.11 | -$0.08 | — | — | $11.13M | $12.58M | — | — | Get Alert |
03/05/2024 | PM | AQST | Q4 | -$0.23 | -$0.08 | -$0.10 | -25.00% | $10.68M | $11.63M | $13.21M | 13.55% | Get Alert |
11/06/2023 | PM | AQST | Q3 | -$0.23 | -$0.11 | -$0.03 | 72.73% | $11.46M | $11.51M | $13.00M | 12.96% | Get Alert |
08/07/2023 | PM | AQST | Q2 | -$0.36 | -$0.11 | -$0.10 | 9.09% | $13.27M | $10.76M | $13.24M | 23.06% | Get Alert |
05/02/2023 | PM | AQST | Q1 | -$0.32 | -$0.19 | $0.11 | 157.89% | $12.27M | $9.94M | $11.13M | 12.01% | Get Alert |
03/07/2023 | PM | AQST | Q4 | -$0.38 | -$0.23 | -$0.23 | 0.00% | $11.08M | $10.42M | $10.68M | 2.51% | Get Alert |
11/01/2022 | PM | AQST | Q3 | -$0.37 | -$0.30 | -$0.23 | 23.33% | $13.29M | $11.04M | $11.46M | 3.83% | Get Alert |
08/02/2022 | PM | AQST | Q2 | -$0.33 | -$0.36 | -$0.36 | 0.00% | $15.35M | $10.57M | $13.27M | 25.50% | Get Alert |
05/03/2022 | PM | AQST | Q1 | -$0.41 | -$0.41 | -$0.32 | 21.95% | $11.12M | $10.11M | $12.27M | 21.36% | Get Alert |
03/08/2022 | PM | AQST | Q4 | -$0.60 | -$0.47 | -$0.38 | 19.15% | $7.15M | $9.36M | $11.08M | 18.35% | Get Alert |
11/02/2021 | PM | AQST | Q3 | -$0.49 | -$0.45 | -$0.37 | 17.78% | $8.26M | $11.01M | $13.29M | 20.68% | Get Alert |
08/03/2021 | PM | AQST | Q2 | -$0.07 | -$0.44 | -$0.33 | 25.00% | $21.68M | $9.48M | $15.35M | 61.87% | Get Alert |
05/04/2021 | PM | AQST | Q1 | -$0.49 | -$0.43 | -$0.41 | 4.65% | $8.77M | $8.97M | $11.12M | 23.99% | Get Alert |
03/09/2021 | PM | AQST | Q4 | -$0.48 | -$0.26 | -$0.60 | -130.77% | $16.42M | $6.25M | $7.15M | 14.38% | Get Alert |
11/04/2020 | PM | AQST | Q3 | -$0.54 | -$0.46 | -$0.49 | -6.52% | $12.42M | $8.72M | $8.26M | -5.28% | Get Alert |
08/04/2020 | PM | AQST | Q2 | -$0.82 | -$0.43 | -$0.07 | 83.72% | $11.13M | $8.77M | $21.68M | 147.15% | Get Alert |
05/05/2020 | PM | AQST | Q1 | -$0.59 | -$0.47 | -$0.49 | -4.26% | $12.64M | $10.07M | $8.77M | -12.96% | Get Alert |
03/11/2020 | PM | AQST | Q4 | -$0.56 | -$0.39 | -$0.48 | -23.08% | $16.82M | $15.84M | $16.42M | 3.66% | Get Alert |
11/05/2019 | PM | AQST | Q3 | — | -$0.69 | -$0.54 | 21.74% | — | $9.97M | $12.42M | 24.55% | Get Alert |
Aquestive Therapeutics (AQST) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on March 5, 2024 for Q4.
The Actual EPS was $-0.10, which missed the estimate of $-0.08.
The Actual Revenue was $13.2M, which beat the estimate of $11.6M.
Browse earnings estimates, EPS, and revenue on all stocks.